Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants

Philip L. Ballard, William E. Truog, Jeffrey D. Merrill, Andrew Gow, Michael Posencheg, Sergio G. Golombek, Lance A. Parton, Xianqun Luan, Avital Cnaan, Roberta A. Ballard

Результат исследований: Материалы для журналаСтатья

43 Цитирования (Scopus)

Аннотация

Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

Язык оригиналаАнглийский
Страницы (с-по)555-561
Число страниц7
ЖурналPediatrics
Том121
Номер выпуска3
DOI
СостояниеОпубликовано - мар 2008
Опубликовано для внешнего пользованияДа

    Fingerprint

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Цитировать

Ballard, P. L., Truog, W. E., Merrill, J. D., Gow, A., Posencheg, M., Golombek, S. G., Parton, L. A., Luan, X., Cnaan, A., & Ballard, R. A. (2008). Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants. Pediatrics, 121(3), 555-561. https://doi.org/10.1542/peds.2007-2479